Hikma Pharmaceuticals PLC (LON:HIK)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 1,694.00
+22.00 (1.32%)
Oct 22, 2026, 4:35 PM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.54 billion as of October 22, 2026. It is the 3,789th most valuable company in the world and the 104th biggest in the United Kingdom. Its market cap has decreased by 10.36% in one year.
Market Cap
3.54B
Enterprise Value
4.81B
Revenue
2.58B
Global Rank
Country Rank
#104 United Kingdom
PE Ratio
12.79
ChartMarket Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.54B, an increase of 653.69%. That is a compound annual growth rate of 10.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.54B | 3.12% |
| Dec 31, 2025 | 3.43B | -22.33% |
| Dec 31, 2024 | 4.42B | 11.74% |
| Dec 29, 2023 | 3.96B | 15.72% |
| Dec 30, 2022 | 3.42B | -33.45% |
| Dec 31, 2021 | 5.14B | -11.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 33.11B |
| HUTCHMED (China) | 1.93B |
| Allergy Therapeutics | 284.96M |
| ECO Animal Health Group | 64.71M |
| Shield Therapeutics | 59.38M |
| Provexis | 21.11M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 915.12K |